Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Operating Expenses | 1,323 | 1,307 | 684 | 0 | 993 |
| Operating Income | -1,323 | -1,307 | -684 | N/A | -993 |
| Interest Expense | 752 | 670 | 388 | 0 | 571 |
| Other Income | -318 | -816 | 238 | 0 | -26 |
| Pre-tax Income | -2,393 | -2,793 | -834 | 0 | -1,590 |
| Net Income Continuous | -2,393 | -2,793 | -834 | N/A | -1,590 |
| Net Income | $-2,393 | $-2,793 | $-834 | $N/A | $-1,590 |
| EPS Basic Total Ops | -335.08 | -390.55 | -116.94 | N/A | -222.64 |
| EPS Basic Continuous Ops | -334.87 | -390.62 | -116.64 | N/A | -222.37 |
| EPS Diluted Total Ops | -335.08 | -390.55 | -116.94 | N/A | -222.64 |
| EPS Diluted Continuous Ops | -334.87 | -390.62 | -116.64 | N/A | -222.37 |
| EBITDA(a) | $-1,317 | $-1,300 | $-677 | $N/A | $-981 |